PATENT CLAIM ANALYSIS

Application Number: 15893341
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["546", "193000"]

Abstract:
Compounds of formula I that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase, pharmaceutical compositions including such compounds and methods of treating diseases, conditions or disorders utilizing such compounds and compositions.

Claim (Index 3):
The compound of  claim 2  wherein one or more of the optional substitutions is chlorine, fluorine, methyl, methoxy, trifluoromethyl or trifluoromethoxy.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 1.2963
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13780510', '11641284', '15613361', '14795466', '15698788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.736325682061925
- 35 USC 102 Novelty (BERT): 0.4984078172172821
- Combined Prediction Score: 0.7125338955774607
- Mean Citation Score: 242.17147600000004
- Max Citation Score: 245.82295
- Similarity Product: 192.23520388681888

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test